BBLG Q3 2018 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q3 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

$404,791

Net Income

-$242,000

EPS (Diluted)

$-19.62

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$101,164

Balance Sheet

Total Assets

$2M

Total Liabilities

$10M

Stockholders' Equity

-$7M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	$404,791	-$1M	+135.8%
Net Income	-$242,000	-$3M	+90.4%